Latest filing published 20 May 2024 for AlzeCure Pharma AB, €1,277.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Birgitta Lundvik: trading record in brief
Birgitta Lundvik discloses dealings in AlzeCure Pharma AB to Finansinspektionen. The record holds 4 filings, for trades running from 9 December 2022 to 17 May 2024.
No open-market sale appears; the market trades are 1 purchase. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 20 May 2024 with a transaction (€1,277) in AlzeCure Pharma AB. The most recent open-market purchase was published on 9 December 2022, 1,429 days ago. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Birgitta Lundvik
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,750 shares@ SEK 1.708.5% of flowBTA (betald tecknad aktie)ISIN SE0022060802FI:csv-daf1f859c059614864d6
- 17,500 shares@ SEK 3.7539.2% of flowBTA (betald tecknad aktie)ISIN SE0019174087FI:csv-fcafdae9ef7fbff27bd0
- 23,330 shares@ SEK 3.7552.3% of flowBTA (betald tecknad aktie)ISIN SE0019174087FI:csv-15d1bf101afe31b05598
- 105,000 shares0Teckningsrätt/UniträttISIN SE0019174079FI:csv-24c4e2561710ff5efc7aCanonical exit: 9 Mar 2023 (T+90)
4 of 4 declarations